Yurek Paprocki, MD, MBA

Yurek Paprocki, MD, MBA

Medical Lead, Ozempic Rybelsus Semaglutide Glp 1 Launch Team, Clinical Development Medical Affairs @ Novo Nordisk

About Yurek Paprocki, MD, MBA

People similar to Yurek Paprocki, MD, MBA